A Win For Virax Biolabs Group Limited
Thu, Nov 03, 2022 at 07:27 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) jumped higher at $2.29, a gain of 36.3%. On Thu, Nov 03, 2022, VRAX:NASDAQ hit a New 2-Week High of $2.29. The stock appeared on our News Catalysts scanner on Thu, Nov 03, 2022 at 11:20 AM in the 'MISCELLANEOUS' category. From Thu, Oct 20, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Jul 29, 2022 at $29 with a volume of 10M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 242.8%
- Renovare Environmental Inc. (RENO:NASDAQ), 77.78%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Acutus Medical Inc. (AFIB:NASDAQ), 39.71%
- NerdWallet Inc. (NRDS:NASDAQ), 37.4%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 36.31%
- Aptose Biosciences Inc. (APTO:NASDAQ), 26.86%
- Provention Bio, Inc. (PRVB:NASDAQ), 26.09%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.61%
- Greenhill & Co., Inc. (GHL:NYSE), 24.59%